Kezar Life Sciences, INC Form 4 insider transactions

Director Elizabeth Garner acquired 50,000 stock options in Kezar Life Sciences, Inc. on June 20, 2024.

Director Courtney Wallace reports acquisition of 50,000 stock options in Kezar Life Sciences, Inc.

Director Graham K. Cooper acquired stock options in Kezar Life Sciences, Inc. on June 20, 2024.

Director Micki Klearman acquired 50,000 stock options in Kezar Life Sciences, Inc. on June 20, 2024.

Franklin M. Berger, a director at Kezar Life Sciences, acquired 50,000 stock options on June 20, 2024, exercisable at $0.67 per share.

Michael Kauffman, a director at Kezar Life Sciences, acquired 50,000 stock options on June 20, 2024, exercisable at $0.67 per share.